Question 1

What is the typical CAPEX range for setting up a Vitamin B1 manufacturing plant?

Accepted Answer

The indicative CAPEX range is USD 18 million to USD 35 million, depending on capacity, route, and product form scope.

Question 2

What is the typical plant capacity or benchmark scale for a Vitamin B1 manufacturing facility?

Accepted Answer

The benchmark plant capacity is 1,000 to 1,500 MT/year of thiamine hydrochloride, consuming 700 to 1,000 MT of acrylonitrile chain feedstocks and 300 to 500 MT of thiazole intermediate inputs per year.

Question 3

What is the current market size and growth rate for Vitamin B1?

Accepted Answer

The global vitamin B1 market is valued at USD 200 million to USD 320 million currently. It is growing at a compound annual growth rate (CAGR) of 5.0% to 5.5%.

Question 4

What are the main end-use segments for Vitamin B1, and what share of demand does each represent?

Accepted Answer

Main segments include pharmaceutical formulations (~40% of demand), dietary supplements and nutraceuticals (~25%), food fortification (~20%), animal feed additives (~12%), and cosmetics and specialty research applications (~3%).

Question 5

What is the reaction or synthesis route and key intermediates used to manufacture Vitamin B1?

Accepted Answer

The dominant Grewe diamine method involves reacting Grewe diamine with a chloroketone and carbon disulfide to form a ketodithiocarbamate intermediate. This intermediate cyclizes to thiothiamine, which is then oxidized and converted to thiamine hydrochloride or thiamine mononitrate.

Question 6

What are the key intermediate or API cost requirements, and what share of raw material cost do they represent?

Accepted Answer

Grewe diamine and chloroketone account for the largest share of raw material cost. Raw materials and feedstocks account for roughly 55–70% of the overall production cost.

Question 7

What share of total capital cost do the core reaction and purification equipment represent?

Accepted Answer

Core process equipment, such as reactors, oxidation vessels, salt formation tanks, crystallizers, and milling and packaging machines, accounts for 50 to 60% of total machinery spend. The share of total capital cost for this equipment is not specified.

Question 8

What factors drive Vitamin B1 manufacturing cost the most?

Accepted Answer

Manufacturing costs are primarily driven by the prices of Grewe diamine, chloroketone, carbon disulfide, and process solvents, with Grewe diamine and chloroketone pricing serving as a main cause of OPEX volatility.

Question 9

In which regions is Vitamin B1 manufacturing capacity concentrated?

Accepted Answer

Manufacturing capacity is highly concentrated in China, which accounts for approximately 90% of global capacity. Europe hosts about 10% of global production, and India has growing capacity.

Question 10

What grades or specifications are available for Vitamin B1?

Accepted Answer

Available grades include feed grade, food grade, pharmaceutical grade meeting USP, EP, and JP standards, and microencapsulated and stabilized forms.

Question 11

What regulatory requirements (FDA, EMA, GMP, DMF filings) apply to Vitamin B1 manufacturing?

Accepted Answer

Manufacturing requires compliance with GMP, pharmacopoeial standards such as USP, EP, and JP, and applicable food-safety regulations.

Vitamin B1 Manufacturing Plant Project Report 2026: Cost Analysis, ROI, and Feasibility Insights

About the Author

Vishakha Agrawal

Frequently Asked Questions